13F Data
13F filer · CIK 1609251

Krensavage Asset Management, LLC

NEW YORK, NY · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$263.2M
+$7.5M vs prior
Positions
18
New / sold out
0 / 2
Added / reduced
4 / 2
Turnover
7.9%
buys $20.4M · sells $24.7M
Top-10 weight
89.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedABBOTT LABORATORIES+195,000+3900.0%+$17.7M
AddedEMBECTA CORP+400,000+54.4%+$1.3M
AddedREGENERON PHARMACEUTICALS+2,000+50.0%+$1.2M
AddedARDELYX INC+34,523+6.9%+$176.1K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outINDIVIOR PHARMACEUTICALS INC-339,532-100.0%$-10.3M
ReducedUNITED THERAPEUTICS CORP-15,000-17.8%$-8.1M
Sold outALKERMES PLC-107,822-100.0%$-3.8M
ReducedEXELIXIS INC-45,000-10.8%$-2.4M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $179.5MQ1 2015: $219.6MQ2 2015: $265.1MQ3 2015: $276.3MQ4 2015: $313.4MQ1 2016: $278.7MQ2 2016: $277.5MQ3 2016: $276.7MQ4 2016: $278.9MQ1 2017: $310.1MQ2 2017: $329.4MQ3 2017: $320.8MQ4 2017: $320.8MQ1 2018: $412.2MQ2 2018: $391.6MQ3 2018: $389.1MQ4 2018: $296.2MQ1 2019: $370.1MQ2 2019: $308.1MQ3 2019: $260.4MQ4 2019: $293.0MQ1 2020: $310.9MQ2 2020: $367.6MQ3 2020: $314.1MQ4 2020: $342.4MQ1 2021: $288.9MQ2 2021: $294.5MQ3 2021: $318.8MQ4 2021: $288.3MQ1 2022: $290.1MQ2 2022: $302.5MQ3 2022: $314.1MQ4 2022: $323.6MQ1 2023: $329.3MQ2 2023: $315.6MQ3 2023: $271.6MQ4 2023: $281.9MQ1 2024: $225.5MQ2 2024: $217.8MQ3 2024: $178.5MQ4 2024: $169.0MQ1 2025: $180.9MQ2 2025: $188.9MQ3 2025: $234.7MQ4 2025: $283.1MQ1 2026: $255.7MQ2 2026: $263.2M
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ENANTA PHARMACEUTICALS INCCOM2,866,138$41.8M15.88%
2JAZZ PHARMACEUTICALS PLCCOM167,816$40.4M15.36%
3UNITED THERAPEUTICS CORPCOM69,282$37.5M14.26%
4BIOMARIN PHARMACEUTICAL INCCOM524,786$30.0M11.41%
5EXELIXIS INCCOM370,693$20.2M7.66%
6ABBOTT LABORATORIESCOM200,000$18.1M6.89%
7SANOFI-ADRCOM323,946$13.8M5.25%
8SUPERNUS PHARMACEUTICALS INCCOM280,681$13.1M4.96%
9ULTRAGENYX PHARMACEUTICAL INCOM390,879$13.1M4.96%
10VANDA PHARMACEUTICALS INCCOM1,180,388$7.2M2.74%
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.